<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" href="https://www.taxtmi.com/rss_sitemap/rss_feed_blog.xsl?v=1750492856"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Court Upholds Tribunal&#039;s Medicated Ointment Tax Classification; Revenue&#039;s Challenge Dismissed Due to Lack of Proof.</title>
    <link>https://www.taxtmi.com/highlights?id=80228</link>
    <description>The case involves the statutory interpretation of Entry 41 of Schedule II of the Act regarding the classification of a product as a medicated ointment. The court emphasized harmonizing inclusive and exclusive clauses in legislative provisions. Entry 41 aims to classify products based on medicinal properties, with medicated ointments receiving favorable tax treatment. The use of &quot;but&quot; in the entry indicates an exception for medicated ointments. The Revenue failed to disprove the product&#039;s classification, highlighting the importance of meeting the burden of proof. The court cited precedents emphasizing the Assessee&#039;s favorable interpretation in charging sections. The Tribunal&#039;s classification of the product as a medicated ointment was support.....</description>
    <language>en-us</language>
    <pubDate>Thu, 08 Aug 2024 09:05:34 +0530</pubDate>
    <lastBuildDate>Thu, 08 Aug 2024 09:05:34 +0530</lastBuildDate>
    <generator>TaxTMI RSS Generator</generator>
    <atom:link href="https://www.taxtmi.com/rss_feed_blog?id=763314" rel="self" type="application/rss+xml"/>
    <item>
      <title>Court Upholds Tribunal&#039;s Medicated Ointment Tax Classification; Revenue&#039;s Challenge Dismissed Due to Lack of Proof.</title>
      <link>https://www.taxtmi.com/highlights?id=80228</link>
      <description>The case involves the statutory interpretation of Entry 41 of Schedule II of the Act regarding the classification of a product as a medicated ointment. The court emphasized harmonizing inclusive and exclusive clauses in legislative provisions. Entry 41 aims to classify products based on medicinal properties, with medicated ointments receiving favorable tax treatment. The use of &quot;but&quot; in the entry indicates an exception for medicated ointments. The Revenue failed to disprove the product&#039;s classification, highlighting the importance of meeting the burden of proof. The court cited precedents emphasizing the Assessee&#039;s favorable interpretation in charging sections. The Tribunal&#039;s classification of the product as a medicated ointment was support.....</description>
      <category>Highlights</category>
      <law>VAT and Sales Tax</law>
      <pubDate>Thu, 08 Aug 2024 09:05:34 +0530</pubDate>
      <guid isPermaLink="true">https://www.taxtmi.com/highlights?id=80228</guid>
    </item>
  </channel>
</rss>